Findings

What do systematic reviews say?

1,281 questions · 1,307 findings · 212 reviews

Sort:Best matchNewest Highest certainty Download CSV

No studies found 256 · 19.6%GRADE not reported 125 · 9.6%Very low 266 · 20.4%Low 403 · 30.8%Moderate 208 · 15.9%High 49 · 3.7%

Herbal preparations plus medication vs medication

Adverse events · women with uterine fibroids

1 finding from 1 review

Herbal preparations for uterine fibroids 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Herbal preparations plus medication vs medication

Average volume of maximum fibroids (cm3) · women with uterine fibroids

1 finding from 1 review

Herbal preparations for uterine fibroids 2013 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Anticholinergic medication vs placebo

Tardive dyskinesia: No clinically important improvement · patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Anticholinergic medication vs other treatments

Adverse effect: any adverse effects · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether anticholinergic medication changes adverse effect: any adverse effects compared with other treatments (very low certainty).

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.33 [0.02, 7.32]
1 study · 20 participants
Very low

Anticholinergic medication vs other treatments

Leaving the study early · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether anticholinergic medication changes acceptability of the treatment: leaving the study early compared with other treatments (very low certainty).

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 0.33 [0.02, 7.32]
1 study · 20 participants
Very low

Anticholinergic medication vs other treatments

Social confidence, social inclusion, social networks, or personalised quality of life · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Anticholinergic medication vs placebo

Tardive dyskinesia: Deterioration of symptoms · patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Anticholinergic medication vs placebo

Mental state · patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Anticholinergic medication vs placebo

Adverse effect: any adverse effects · patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Anticholinergic medication vs placebo

Leaving the study early · patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Anticholinergic medication vs placebo

Social confidence, social inclusion, social networks, or personalised quality of life · patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Anticholinergic medication vs other treatments

Tardive dyskinesia: No clinically important improvement · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia

It is very uncertain whether anticholinergic medication changes tardive dyskinesia: Not improved to a clinically important extent compared with other treatments (very low certainty).

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
RR 4.2 [1.4, 12.58]
1 study · 20 participants
Very low

Anticholinergic medication vs other treatments

Tardive dyskinesia: Deterioration of symptoms · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Anticholinergic medication vs other treatments

Mental state · chronic schizophrenia patients with antipsychotic‐induced tardive dyskinesia

1 finding from 1 review

Anticholinergic medication for antipsychotic‐induced tardive dyskinesia 2018 · Cochrane Headline outcomes only
no estimate extracted
0 studies · 0 participants
GRADE not reported

Mobile phone interventions vs usual care

Objective measure of medication adherence: Cholesterol (low‐density lipoprotein) · people prescribed medication for primary prevention of cardiovascular disease

1 finding from 1 review

Mobile phone‐based interventions for improving adherence to medication prescribed for the primary prevention of… 2021 · Cochrane Headline outcomes only
no estimate extracted
5 studies · 5441 participants
Low

Mobile phone interventions vs usual care

Objective measure of medication adherence: Blood pressure · people prescribed medication for primary prevention of cardiovascular disease

1 finding from 1 review

Mobile phone‐based interventions for improving adherence to medication prescribed for the primary prevention of… 2021 · Cochrane Headline outcomes only
no estimate extracted
13 studies · 25166 participants
Low

Intervention not reported

Medication‐taking ability · older patients using at least 4 regular prescription medications (and/or their carers)

1 finding from 1 review

Interventions for improving medication‐taking ability and adherence in older adults prescribed multiple medications 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Intervention not reported

Medication‐taking ability · older patients using at least 4 regular prescription medications (and/or their carers)

The review found no eligible studies for this question.

1 finding from 1 review

Interventions for improving medication‐taking ability and adherence in older adults prescribed multiple medications 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

Intervention not reported

Medication adherence (dichotomous) · older patients using at least 4 regular prescription medications (and/or their carers)

1 finding from 1 review

Interventions for improving medication‐taking ability and adherence in older adults prescribed multiple medications 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Low

Intervention not reported

Medication adherence (continuous) · older patients using at least 4 regular prescription medications (and/or their carers)

1 finding from 1 review

Interventions for improving medication‐taking ability and adherence in older adults prescribed multiple medications 2020 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
Very low